CEO Evan Feinberg (Boris Feldman)
A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
Evan Feinberg could have picked a better time to launch his AI biotech, Genesis. He announced a $4.1 million round last November; by March …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
